FUNDAMENTALS · Fundamentals · SG Healthcare

UG Healthcare (8K7) Fundamentals 2026 — Revenue Analysis | SniperIQ

UG Healthcare (8K7) is a SG-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of S$51M, trading at S$0.08 on the SES. This SniperIQ fundamentals page covers UG Healthcare's valuation, profitability (net margin -2.6%), revenue (S

44M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapS$51M
Net Margin-2.6%
Revenue (FY25)S
44M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is UG Healthcare's market cap?

UG Healthcare (8K7) has a market capitalization of approximately S$51M, trading at S$0.08 on the SES. Market cap moves with the live share price.

What is UG Healthcare's P/E ratio?

UG Healthcare's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is UG Healthcare?

UG Healthcare runs a net profit margin of -2.6%, a gross margin of 24.1%, and an operating margin of -0.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does UG Healthcare generate?

UG Healthcare reported revenue of S

44M for fiscal year 2025, with net income of -S$4M and earnings per share (EPS) of -0.0061. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does UG Healthcare pay a dividend?

UG Healthcare does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is UG Healthcare financially healthy?

UG Healthcare carries a debt-to-equity ratio of 0.30x and a current ratio of 2.70x, with a market beta of 0.93. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is UG Healthcare a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For UG Healthcare (8K7) the key facts are: market cap S$51M, revenue S

44M, 52-week range 0.072-0.111. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track UG Healthcare's full fundamentals live

Get UG Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Seres Therapeutics (MCRB) fundamentals · Sensus Healthcare (SRTS) fundamentals · SANUWAVE Health (SNWV) fundamentals · BeyondSpring (BYSI) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons